Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
18 studies found for:    CB2
Show Display Options
Rank Status Study
1 Completed A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis
Condition: Osteoarthritis
Intervention: Drug: GW842166
2 Completed Dental Pain 3rd Molar Tooth Extraction GW842166
Condition: Pain
Intervention: Drug: GW842166
3 Completed An Imaging Study to Investigate the Distribution of GW842166X in the Brain.
Conditions: Analgesia;   Inflammation;   Pain, Inflammatory
Intervention: Drug: GW842166X
4 Completed A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: 50 mg S-777469;   Drug: 200 mg S-777469;   Drug: 800 mg S-777469;   Drug: Placebo
5 Withdrawn Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.
Condition: Healthy Subjects
Intervention: Drug: GW842166X
6 Not yet recruiting JBT-101 in Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus;   SLE;   Lupus
Interventions: Drug: JBT-101;   Drug: Placebo
7 Completed Cabergoline Reduces OHSS
Condition: Ovarian Hyperstimulation Syndrome
Interventions: Drug: Cabergoline;   Procedure: MR;   Procedure: Ultrasound;   Procedure: Blood Analysis
8 Unknown  Use of Cannabinoids in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Sativex
9 Recruiting Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients
Conditions: Non-Small Cell Lung Cancer;   Anorexia;   Cachexia;   Weight Lose
Interventions: Drug: Nabilone;   Drug: Placebo
10 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
11 Unknown  Cannabis for Inflammatory Bowel Disease
Conditions: Crohn's Disease;   Ulcerative Colitis
Interventions: Drug: smoking of cannabis;   Drug: smoking cigarettes with placebo
12 Completed
Has Results
The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain
Condition: Chest Pain
Interventions: Drug: Marinol;   Drug: Placebo
13 Unknown  Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
Condition: Diabetic Neuropathies
Intervention: Drug: Nabilone, flexible dosing
14 Enrolling by invitation The Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Other: CBD chewing gum;   Other: Placebo
15 Withdrawn Supplementation of Lycopene in Carotid Atheroma
Condition: Carotid Atherosclerotic Disease
Interventions: Drug: Placebo;   Dietary Supplement: Ateronon
16 Unknown  Lycopene Following Aneurysmal Subarachnoid Haemorrhage
Conditions: Subarachnoid Hemorrhage;   Aneurysm
Interventions: Drug: Lycopene;   Drug: placebo
17 Recruiting Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Low-risk Early Stage Cervical Cancer (SHAPE)
Condition: Cervical Cancer
Interventions: Procedure: Radical Hysterectomy + pelvic lymph node dissection;   Procedure: Simple hysterectomy + pelvic lymph node dissection
18 Not yet recruiting IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism
Conditions: Primary Aldosteronism;   Hyperaldosteronism
Intervention: Procedure: adrenalectomy

Study has passed its completion date and status has not been verified in more than two years.